Adverse effects and drug resistance to the current onchopharmacologicals have increased the demand for alternative novel therapeutics. We herein introduce justicidin B, an arylnaphthalen lignan isolated from different plant origins, especially Justicia, Phyllanthus, Haplophyllum and Linum species. This cyclolignan exhibits a wide array of biological properties ranges from piscicidal to antifungal, antiviral and antibacterial activities. Activity against Trypanosoma brucei makes justicidin B a potential antiprotozoal agent for the treatment of neglected tropical diseases. Pharmacological properties like antiplatelet, anti-inflammatory and bone resorption inhibition have been also attributed to justicidin B. This compound is a potent cytotoxic substance on several cell lines, especially chronic myeloid and chronic lymphoid leukemia. Pharmacological values, natural variation, as well as biotechnological production of justicidin B by plant cell, tissue and organ culture are also described in this review. Chemical characteristics and chromatographic methods to identify justicidin B and its biosynthetic pathway have been discussed. Different approaches to the total synthesis of justicidin B are compared. This review would shed light on the role of justicidin B as an intriguing natural compound and provides a chance to optimize conditions for industrial applications.
Lignans in higher plants represent an ideal class of natural products to be investigated for the origin of stereochemical diversity since chiral lignans occur in pure enantiomeric form as well as in enantiomeric mixtures. Seeds of Linum usitatissimum contain 8S, 8′S-(+)- and 8R, 8′R-(−)-secoisolariciresinol [SS-(+)- and RR-(−)-secoisolariciresinol, respectively] as diglucosides (SS- and RR-secoisolariciresinol diglucosides) whereas aerial parts of flowering L. usitatissimum accumulate only lignans derived from RR-(−)-secoisolariciresinol. Pinoresinol-lariciresinol reductase (PLR) catalyzes two early steps in lignan biosynthesis. Up to now, only a cDNA encoding a PLR (PLR‐Lu1) which is enantiospecific for the conversion of 8S, 8′S-(−)-pinoresinol (SS-pinoresinol) via 8S, 8′S-(−)-lariciresinol (SS-lariciresinol) to SS-(+)-secoisolariciresinol was cloned. Here we present the cloning of a cDNA encoding a RR-pinoresinol-RR-lariciresinol reductase (PLR‐Lu2) from the leaves of L. usitatissimum which converts only RR-pinoresinol to RR-secoisolariciresinol. In leaves and stems of L. usitatissimum accumulating the 8R, 8′R-enantiomers of lignans, only PLR‐Lu2 was transcriptionally active. Both PLR‐Lu1 and PLR‐Lu2 transcripts were observed in seeds and contribute to the synthesis of SS- and RR-secoisolariciresinol, respectively. Thus, the enantiomeric composition of lignans in the organs of L. usitatissimum appears to be determined by the relative action of two PLRs with opposite enantiospecificities rather than by a single enzyme of low enantiospecificity. 1 Dedicated to Prof. Dr. Wolfgang Barz on the occasion of his 75th birthday.
12 April 2015 in International Journal of Peptide Research and Therapeutics